Elarova | Orthopädische Ledersandalen

Marsoni

M251S

$55.95

Get it in 3 business days with 1 day shipping. Friday, May 29

Elarova | Orthopädische LedersandalenImproved comfort and pain relief from feet to back Premium orthopedic insoles with adjustable arch support and multiple layers of foam provide comfortable, pillow like support that enhances comfort and relieves foot, heel, knee, hip, and lower back pain. By relieving pressure on your joints, you can stand up pain free. Ideal for people who spend long hours on their feet. Excellent stability, walking comfort, ideal fit, lightweight and ergonomic soles

Easy Shipping

Quick Dispatch:

Your Elarova | Orthopädische Ledersandalen orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your Elarova | Orthopädische Ledersandalen ships.

Need Help?
Questions about Elarova | Orthopädische Ledersandalen, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for Elarova | Orthopädische Ledersandalen in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

These run very small. I was advised by my sister before ordering that Mini Melissa runs small; however, my daughter is a size 11 or 11.5 and since these run in whole sizes I couldn’t imagine ordering a 12! I would think a size 12 would be a range of shoe sizes 12 to 13. They arrived in time for an event we needed them for but were way too short in length so unfortunately they were returned. They are lovely, adorable, comfortable shoes but run very very small.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on June 13, 2025